A new report highlights the dangers of overprescribing tranquilisers, sleeping pills, and painkillers, which jeopardizes patient safety and contributes to drug-related fatalities. It emphasizes the urgent need for increased awareness regarding these risks. The report also recommends that pregabalin and gabapentin, common medications for pain relief, should be classified as controlled substances, aligning with regulations in other nations to enhance monitoring and safety protocols. The call to action includes a plea for greater public and healthcare provider understanding of the inherent risks associated with these drugs.
Overprescribing of tranquilisers, sleeping pills and certain painkillers compromises patient safety and increases drug-related deaths, emphasizing the need for heightened awareness of these dangers.
The report advocates for positioning pregabalin and gabapentin on the controlled drugs list to mitigate risks, mirroring the actions taken by other countries.
Collection
[
|
...
]